Sign in to view content

Predictive Modeling of Proliferative Diabetic Retinopathy and DME Based on Analysis of High-Value Biomarkers

Kameran Lashkari, MD, FASRS

Video
Published 2019

Related

Optical Coherence Tomography Angiography Biomarkers for Predicting Visual Outcomes after Ranibizumab Treatment for Diabetic Macular Edema
Yi-Ting Hsieh, MD
On Demand Cases, Courses, and Papers
2019
Five-Year Outcomes After Initial Aflibercept, Bevacizumab, or Ranibizumab Treatment for Diabetic Macular Edema (Protocol T)
Dante Joseph Pieramici, MD
Annual Meeting Talks
2020
Impact of Initial Monthly Doses of Aflibercept on Visual Outcomes in Eyes With Diabetic Macular Edema in Routine Clinical Practice in the US
Ferhina S Ali, MD, MPH
Annual Meeting Talks
2023

Category: Diabetic Retinopathy

See more